Learn More
BACKGROUND Atherosclerosis is the leading cause of death in hemodialysis patients. These patients are also very prone to L-carnitine deficiency due to kidney disease. In this clinical trial, we investigated the effect of oral L-carnitine on endothelial function of these patients. MATERIALS AND METHODS [corrected] We studied 31 adult chronic hemodialysis(More)
  • 1